Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers

por Prodeus, Aaron, Abdul-Wahid, Aws, Fischer, Nicholas W., Huang, Eric H-B, Cydzik, Marzena, Gariépy, Jean
Publicado 2015

Syngeneic tobacco carcinogen–induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden

por Stabile, Laura P., Kumar, Vinod, Gaither-Davis, Autumn, Huang, Eric H., Vendetti, Frank P., Devadassan, Princey, Dacic, Sanja, Bao, Riyue, Steinman, Richard A., Burns, Timothy F., Bakkenist, Christopher J.
Publicado 2021

Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

por Yochum, Zachary A., Cades, Jessica, Wang, Hailun, Chatterjee, Suman, Simons, Brian W., O’Brien, James P., Khetarpal, Susheel K., Lemtiri-Chlieh, Ghali, Myers, Kayla V., Huang, Eric H.-B., Rudin, Charles M., Tran, Phuoc T., Burns, Timothy F.
Publicado 2018